Skip to main content
Clinical Trials/NCT01577251
NCT01577251
Recruiting
Not Applicable

Registry and Biosample Repository

Abramson Cancer Center at Penn Medicine4 sites in 1 country8,000 target enrollmentJune 1, 2008
ConditionsNeoplasia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neoplasia
Sponsor
Abramson Cancer Center at Penn Medicine
Enrollment
8000
Locations
4
Primary Endpoint
Health Assessments
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Registry
clinicaltrials.gov
Start Date
June 1, 2008
End Date
December 1, 2030
Last Updated
last month
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy
  • Able to sign consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Health Assessments

Time Frame: 10 years

Study Sites (4)

Loading locations...

Similar Trials